KBL Merger
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KBL Merger and buy or sell other stocks, ETFs, and their options commission-free!About KBLM
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J.
CEOBlair Jordan, MBA
CEOBlair Jordan, MBA
Employees3
Employees3
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded2016
Founded2016
Employees3
Employees3
KBLM Key Statistics
Market cap18.46M
Market cap18.46M
Price-Earnings ratio-0.21
Price-Earnings ratio-0.21
Dividend yield—
Dividend yield—
Average volume54.03K
Average volume54.03K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$17.75
52 Week high$17.75
52 Week low$0.6578
52 Week low$0.6578
People also own
Based on the portfolios of people who own KBLM. This list is generated using Robinhood data, and it’s not a recommendation.